Original language | American English |
---|---|
Journal | Gut |
Volume | 70 |
DOIs | |
State | Published - 2021 |
SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) AND/OR OTHER ORAL ANTIVIRALS (OAVS) TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: FINAL 2-YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 2
Young-Suk Lim, Chun-Yen Lin, Jeong Heo, Ho Bae, Wan-Long Chuang, Tak Yin, Owen Tsang, Claire Fournier, Aric Josun Hui, Huy Trinh, Carol Yee Kwan Chan, Susanna K. Tan, Yang Zhao, John F. Flaherty, Vithika Suri, Anuj Gaggar, Dianna M. Brainard, Stephen Ryder, Harry La Janssen
Research output: Contribution to journal › Journal Article › peer-review